Clinical Trials for X-396

1 Open Trial

Trial TypeProtocol No. &
Open Date
Summary
TreatmentVICCTHN1244
07/25/2012
Phase 1, First-in-Human, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of X-396 in Patients with Advanced Solid Tumors

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.